New York State Common Retirement Fund’s Ginkgo Bioworks DNA Stock Holding History

New York State Common Retirement Fund’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Hold	12,300	–	–	﹤0.01%	2588
2026 Q1	$75.4K	Hold	12,300	–	–	﹤0.01%	2654
2025 Q4	$102K	Hold	12,300	–	–	﹤0.01%	2590
2025 Q3	$179K	Hold	12,300	–	–	﹤0.01%	2338
2025 Q2	$138K	Buy	+12,300	New	+$95.3K	﹤0.01%	2416
2024 Q3	–	Sell	-3,365	Closed	-$45K	–	3224
2024 Q2	$45K	Sell	3,365 -18,505	-85%	-$552K	﹤0.01%	3111
2024 Q1	$1.01M	Sell	21,870 -4,175	-16%	-$216K	﹤0.01%	1770
2023 Q4	$1.76M	Sell	26,045 -3,127	-11%	-$191K	﹤0.01%	1518
2023 Q3	$2.11M	Sell	29,172 -4,756	-14%	-$380K	﹤0.01%	1431
2023 Q2	$2.52M	Buy	33,928 +12,815	+61%	+$759K	﹤0.01%	1412
2023 Q1	$1.12M	Hold	21,113	–	–	﹤0.01%	1818
2022 Q4	$1.43M	Hold	21,113	–	–	﹤0.01%	1807
2022 Q3	$2.63M	Sell	21,113 -835	-4%	-$99.5K	﹤0.01%	1473
2022 Q2	$2.09M	Buy	+21,948	New	+$2.68M	﹤0.01%	1627

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

New York State Common Retirement Fund's DNA Position: Q2 2026 in Review

New York State Common Retirement Fund held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 12,300 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

New York State Common Retirement Fund first reported a position in DNA in Q2 2022 and has held it in 14 quarters since. The position peaked at $2.63M in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

New York State Common Retirement Fund held 12,300 shares of Ginkgo Bioworks worth $122K as of Q2 2026.
New York State Common Retirement Fund left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2588 holding.
New York State Common Retirement Fund first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 14 quarters since.
New York State Common Retirement Fund's Ginkgo Bioworks position peaked at $2.63M in Q3 2022.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.